Neoadjuvantes Nivolumab in Kombination mit platinbasierter Chemotherapie bei operablem LungenkrebsNeoadjuvant nivolumab in combination with platinum-based chemotherapy for operable lung cancer

被引：0
|
作者：
Khosro Hekmat
Christiane J. Bruns
机构：
[1] Universität zu Köln,Klinik und Poliklinik für Herz
[2] Universität zu Köln, und Thoraxchirurgie
来源：
Die Chirurgie | 2023年 / 94卷 / 1期
关键词：
D O I：
10.1007/s00104-022-01778-6
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：77 / 78
页数：1
相关论文
共 50 条
  • [1] Perioperatives Nivolumab in Kombination mit platinbasierter Chemotherapie bei Lungenkrebs im Stadium IIIPerioperative nivolumab in combination with platinum-based chemotherapy for stage III lung cancer
    Khosro Hekmat
    Christiane J. Bruns
    Die Chirurgie, 2024, 95 (2) : 161 - 162
  • [2] Neoadjuvant nivolumab in combination with platinum-based chemotherapy for operable lung cancer
    Hekmat, Khosro
    Bruns, Christiane J.
    CHIRURGIE, 2022,
  • [3] Perioperative nivolumab in combination with platinum-based chemotherapy for stage III lung cancer
    Hekmat, Khosro
    Bruns, Christiane J.
    CHIRURGIE, 2024, 95 (02): : 161 - 162
  • [4] Nivolumab in Combination With Platinum-Based Doublet Chemotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer
    Rizvi, Naiyer A.
    Hellmann, Matthew D.
    Brahmer, Julie R.
    Juergens, Rosalyn A.
    Borghaei, Hossein
    Gettinger, Scott
    Chow, Laura Q.
    Gerber, David E.
    Laurie, Scott A.
    Goldman, Jonathan W.
    Shepherd, Frances A.
    Chen, Allen C.
    Shen, Yun
    Nathan, Faith E.
    Harbison, Christopher T.
    Antonia, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (25) : 2969 - +
  • [5] Risiko von Zweitmalignomen nach platinbasierter Chemotherapie von HodentumorenRisk of second malignancies after platinum-based chemotherapy of testicular cancer
    David Utz
    Arndt-Christian Müller
    Strahlentherapie und Onkologie, 2019, 195 : 190 - 191
  • [6] Nivolumab in advanced non-small-cell lung cancer patients who failed prior platinum-based chemotherapy
    Lee, Jong Seok
    Lee, Ki Hyeong
    Cho, Eun Kyung
    Kim, Dong-Wan
    Kim, Sang-We
    Kim, Joo-Hang
    Cho, Byoung Chul
    Kang, Jin Hyoung
    Han, Ji-Youn
    Min, Young Joo
    Park, Keunchil
    LUNG CANCER, 2018, 122 : 234 - 242
  • [7] Nivolumab as Maintenance Therapy Following Platinum-Based Chemotherapy in EGFR-mutant Lung Cancer Patients After TKI Failure
    Kim, J.
    Choi, C. -M.
    Lee, J. C.
    Ji, W.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S615 - S615
  • [8] Real-World Clinical Outcomes of Neoadjuvant Platinum-Based Chemotherapy with Nivolumab in Non-Small Cell Lung Cancer
    Shalata, Walid
    Daher, Sameh
    Rabinovitch, Natali Maimon
    Shamai, Sivan
    Kian, Waleed
    Turgeman, Ilit
    Dudnik, Yulia
    Kazareen, Olga
    Rovitsky, Yulia
    Sabo, Edmond
    Faber, Dan Levy
    Galili, Ronen
    Wiesel, Ory
    Baranovsky, Konstantin
    Agbarya, Abed
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (21)
  • [9] FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy
    Kazandjian, Dickran
    Suzman, Daniel L.
    Blumenthal, Gideon
    Mushti, Sirisha
    He, Kun
    Libeg, Meredith
    Keegan, Patricia
    Pazdur, Richard
    ONCOLOGIST, 2016, 21 (05): : 634 - 642
  • [10] A pilot study of ipilimumab and nivolumab in recurrent extensive-stage small cell lung cancer after platinum-based chemotherapy.
    Chiang, Anne C.
    Austin, Matthew
    Stewart, Tyler F.
    Arammash, Mohammad
    Bhatt, Sunil
    Gettinger, Scott N.
    Goldberg, Sarah B.
    Wilson, Frederick Hugh
    Newton, Benjamin Robert
    Cohenuram, Michael Keith
    Sabbath, Kert D.
    Talsania, Ashita D.
    Russo, Armand Vincent
    Herbst, Roy S.
    Schalper, Kurt A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345